T0	Participants 34 77	cervical intraepithelial neoplasia grade 3.
T1	Participants 224 294	cervical intraepithelial neoplasia grade 3 (CIN3), cervical precancer.
T2	Participants 509 574	women with equivocal (ASCUS) or mildly abnormal (LSIL) Pap tests.
T3	Participants 619 728	608 women had a histopathologic diagnosis of CIN3 and PCR-based HPV genotyping results on cervical specimens.
T4	Participants 892 921	608 women diagnosed with CIN3